描述：
Fas, also known as APO-1 or CD95, belongs to the death receptor subfamily of the TNF
receptor superfamily and is designated TNFRSF6. The 335 amino acid (aa) human Fas includes
a 25 aa signal peptide, a 148 aa extracellular domain (ECD) with three cysteinerich TNFR
repeats, a 17 aa transmembrane sequence, and a 145 aa cytoplasmic domain containing a
death domain (DD), which is required for transducing apoptotic signals. Mature human Fas
ECD shares 55%, 58%, 62%, 63%, and 64% aa sequence identity with mouse, rat, feline,
bovine and porcine Fas, respectively. A human Fas isoform of 314 aa that lacks the
transmembrane sequence is secreted by resting lymphocytes, while isoforms of 149, 132,
103 and 86 aa that also lack the DD and show substitutions for parts of the TNFR repeats are
less prominently expressed. All appear to block the extrinsic apoptosis pathway induced by
the Fas ligand (FasL, TNFSF6), a type II transmembrane protein of the TNF family that can be
expressed on activated T-lymphocytes, NK cells and cells in immune privileged sites, or shed
in soluble form. Engagement of FAS induces oligomerization of preformed Fas trimers. The
activated receptor recruits the adaptor molecule FADD to form the Death-Inducing Signaling
Complex (DISC). Upon activation, caspases in the DISC initiate the apoptotic signaling cascade.
Fas is prominent in epithelial cells, hepatocytes, activated mature lymphocytes, virus
transformed lymphocytes and tumor cells. It is an essential mediator in the activation-induced
death of T lymphocytes that terminates the immune reaction. In immune-privileged tissues,
infiltrating Fas-bearing lymphocytes and inflammatory cells are killed by FasL engagement.
Both humans and mice with genetic defects in Fas accumulate abnormal lymphocytes and
develop systemic autoimmunity. The Fas pathway also appears to cross-communicate with
the BIM (mitochondrial/intrinsic) apoptosis pathway.
原厂资料：
Fas, also known as APO-1 or CD95, belongs to the death receptor subfamily of the TNF
receptor superfamily and is designated TNFRSF6. The 335 amino acid (aa) human Fas includes
a 25 aa signal peptide, a 148 aa extracellular domain (ECD) with three cysteinerich TNFR
repeats, a 17 aa transmembrane sequence, and a 145 aa cytoplasmic domain containing a
death domain (DD), which is required for transducing apoptotic signals. Mature human Fas
ECD shares 55%, 58%, 62%, 63%, and 64% aa sequence identity with mouse, rat, feline,
bovine and porcine Fas, respectively. A human Fas isoform of 314 aa that lacks the
transmembrane sequence is secreted by resting lymphocytes, while isoforms of 149, 132,
103 and 86 aa that also lack the DD and show substitutions for parts of the TNFR repeats are
less prominently expressed. All appear to block the extrinsic apoptosis pathway induced by
the Fas ligand (FasL, TNFSF6), a type II transmembrane protein of the TNF family that can be
expressed on activated T-lymphocytes, NK cells and cells in immune privileged sites, or shed
in soluble form. Engagement of FAS induces oligomerization of preformed Fas trimers. The
activated receptor recruits the adaptor molecule FADD to form the Death-Inducing Signaling
Complex (DISC). Upon activation, caspases in the DISC initiate the apoptotic signaling cascade.
Fas is prominent in epithelial cells, hepatocytes, activated mature lymphocytes, virus
transformed lymphocytes and tumor cells. It is an essential mediator in the activation-induced
death of T lymphocytes that terminates the immune reaction. In immune-privileged tissues,
infiltrating Fas-bearing lymphocytes and inflammatory cells are killed by FasL engagement.
Both humans and mice with genetic defects in Fas accumulate abnormal lymphocytes and
develop systemic autoimmunity. The Fas pathway also appears to cross-communicate with
the BIM (mitochondrial/intrinsic) apoptosis pathway.
京公网安备11010802025653 版权所有：北京逸优科技有限公司
